Sunbed Regulations Useless Says Scottish Parliament Health Committee
A health committee of the Scottish parliament said the regulations covering sunbeds and tanning machines offered for public use in commercial parlours are "useless" and do not protect the public, after reviewing evidence from the industry, environmental health and medical research.
What Is Acne Vulgaris?
Acne vulgaris is the medical term for common acne. Acne is widespread among teenagers, although a smaller percentage of adults in their 30's and 40's still get acne. Common acne is characterized by the presence of one or all of the following: whiteheads, blackheads, papules, pustule or pimples that are seen on the face, chest, back, shoulders, even neck.
Acne Treatment Guide
Acne is one of the most common skin disorders in both males and females, occurring on the chest, face, shoulders and back. Almost everyone between the age of puberty and adulthood experiences acne. Because of the prevalence of acne, many people search for an acne treatment, often for various reasons.
Acne Glossary - 40 Terms Commonly Used When Talking writing About Acne
Acne: The general term for clogged skin pores which includes blackheads and whiteheads, as well as severe kind like cysts or nodules, usually found on the face, neck, chest, back, and shoulders. Acne vulgaris: The medical term for common acne, which manifests itself as blackheads, whiteheads, papules and pustules.
FDA Approves Taclonex Scalp R Once Daily Therapy For Treatment Of Moderate To Severe Scalp Psoriasis
Warner Chilcott and LEO Pharma announced that the United States Food and Drug Administration (FDA) has approved the New Drug Application (NDA) for Taclonex Scalp(R) (calcipotriene 0.005% and betamethasone dipropionate 0.064%) Topical Suspension. LEO Pharma submitted the NDA for Taclonex Scalp(R) to the FDA in July 2007.
Advanced Wound Closure Techniques Replacing Sutures And Staples
As the number of surgical procedures performed annually in the developed world increases, clinicians and healthcare decision makers are showing an increased interest in new methods for closing and sealing surgical wounds.
Bio Washing Powder Rashes A 'Myth'
"Washing powders cleared of causing rashes, " reads the headline in The Daily Telegraph yesterday. The newspaper describes a study that claims the idea that "biological washing powders can trigger skin irritations is a myth with no scientific basis". In the UK in particular, it has been suggested that biological powders and liquid detergents containing enzymes that "digest" dirt and stains, can irritate the skin or aggravate eczema.
Acne Not Just A Teen Issue
While acne may traditionally be viewed as a teenage "rite of passage, " results from a groundbreaking national survey released show that acne is a problem that also commonly affects adults. The survey finds that acne can negatively impact many aspects of a person's life -- professional, academic, physical and social -- and a basic lack of knowledge may be preventing or hindering appropriate treatment options.
Nail Salon Workers - Repeated And Prolonged Exposure To Variety Of Chemicals Could Put Workers At Risk
They pamper us and make us feel special. They work long hours for low wages and English is usually their second language, if then. They are mainly Vietnamese women who make their living giving manicures and pedicures. They also suffer from acute health effects associated with the chemicals they use in that work, according to a new survey from the Northern California Cancer Center and Asian Health Services of Oakland.
Elesclomol Study Shows Significant Improvement In Progression Free Survival For Chemotherapy Na Atilde; macr;ve Patients With Metastatic Melanoma
GlaxoSmithKline and Synta Pharmaceuticals Corp announced positive Phase II clinical data for elesclomol (formerly STA-4783), an investigational agent currently in development for metastatic melanoma. A retrospective analysis showed that stage IV metastatic melanoma patients treated with elesclomol and paclitaxel who had not previously received chemotherapy had a statistically significant improvement in progression-free survival (PFS) compared to patients who received paclitaxel alone.